Lionco Pharmaceutical Group Co.,Ltd. (SHA:603669)
4.830
+0.150 (3.21%)
Apr 10, 2026, 10:40 AM CST
27.44% (1Y)
| Market Cap | 3.29B -4.1% |
| Revenue (ttm) | 430.61M +55.3% |
| Net Income | -118.38M |
| EPS | -0.16 |
| Shares Out | 703.54M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 11,451,700 |
| Average Volume | 19,376,400 |
| Open | 4.690 |
| Previous Close | 4.680 |
| Day's Range | 4.560 - 4.830 |
| 52-Week Range | 3.450 - 7.050 |
| Beta | 0.33 |
| RSI | 51.48 |
| Earnings Date | Apr 25, 2026 |